DRI-ecstasy plus mdma/MDA reagent kit

Ended Awarded

Contract number
N6854623F6053
Awardee
Awarding agency
Obligated
$10,434

Award facts

Contract value 100% obligated
$10,433.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fremont, CA 94538, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of the Navy Bureau of Medicine and Surgery awarded a $10,433.80 firm fixed price delivery order contract to Microgenics Corporation, a Clinical Diagnostics Division of Thermo Electron Corporation, for DRI-ECSTASY PLUS MDMA/MDA reagent kits. The contract has no set-aside designation and requires delivery by April 21, 2023 to a location in Fremont, California. As the Bureau of Medicine and Surgery supports the Navy and Marine Corps through healthcare services and research activities, these reagent kits will likely aid in their substance screening and identification efforts.

Quick answers

Who was awarded contract N6854623F6053?

N6854623F6053 was awarded to Microgenics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on April 13, 2023.

How much is contract N6854623F6053 worth?

The government has obligated $10,434 on N6854623F6053.

Is contract N6854623F6053 an order under another contract?

Yes. N6854623F6053 is a delivery order under N6264519D5003, an indefinite delivery contract.

Was contract N6854623F6053 competed?

The extent of competition for N6854623F6053 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award